Centricity Wealth Management LLC Buys New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Centricity Wealth Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 91 shares of the medical equipment provider’s stock, valued at approximately $47,000.

A number of other institutional investors also recently made changes to their positions in ISRG. Howard Capital Management Group LLC raised its stake in Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares during the last quarter. Foundations Investment Advisors LLC grew its holdings in shares of Intuitive Surgical by 8.5% during the third quarter. Foundations Investment Advisors LLC now owns 590 shares of the medical equipment provider’s stock worth $290,000 after buying an additional 46 shares in the last quarter. Private Advisor Group LLC raised its position in shares of Intuitive Surgical by 6.4% in the third quarter. Private Advisor Group LLC now owns 14,910 shares of the medical equipment provider’s stock valued at $7,325,000 after buying an additional 891 shares during the last quarter. McAdam LLC purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $225,000. Finally, International Assets Investment Management LLC lifted its stake in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $591.79 on Friday. The company has a market capitalization of $210.78 billion, a price-to-earnings ratio of 92.32, a PEG ratio of 5.87 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business has a 50-day moving average of $565.45 and a 200-day moving average of $524.52.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 in the last 90 days. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Truist Financial boosted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Royal Bank of Canada increased their target price on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.